Results 1 - 10 of 37 for SORAFENIB
  1. Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys). Sorafenib is also used to treat hepatocellular carcinoma (a ...
  2. Sorafenib Improves Progression-Free Survival in Some Patients with Metastatic Thyroid Cancer Summary Results from an international phase III trial show that sorafenib (Nexavar®) may benefit patients with locally advanced or ...
  3. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... are being done to help answer these questions. Sorafenib (Nexavar ® ) Sorafenib acts by blocking both angiogenesis and growth-stimulating molecules in the cancer cell itself. Sorafenib does this by blocking several tyrosine kinases that ...
  4. General Information about Thyroid Cancer From the National Institutes of Health (National Cancer Institute)  
    ... signals needed for tumors to grow. Vandetanib and sorafenib are tyrosine kinase inhibitors that are used to ... therapy . Targeted therapy with a tyrosine kinase inhibitor ( sorafenib ). Surgery to remove cancer from areas where it ...
  5. ... promise against thyroid cancer in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq ® ), motesanib ( ... Some of these other drugs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other ...
  6. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Kaposi sarcoma: Alitretinoin (Panretin®) Kidney cancer: Bevacizumab (Avastin®) , sorafenib (Nexavar®) , sunitinib (Sutent®) , pazopanib (Votrient®) , temsirolimus (Torisel®) , everolimus ( ...
  7. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... activate the VEGF receptor. Other angiogenesis inhibitors, including sorafenib and sunitinib, bind to receptors on the surface ... approved other drugs that have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). ...
  8. Stages of Thyroid Cancer From the National Institutes of Health (National Cancer Institute)  
    ... signals needed for tumors to grow. Vandetanib and sorafenib are tyrosine kinase inhibitors that are used to ... therapy . Targeted therapy with a tyrosine kinase inhibitor ( sorafenib ). Surgery to remove cancer from areas where it ...
  9. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Cyclophosphamide) Netupitant and Palonosetron Hydrochloride Neupogen (Filgrastim) Nexavar (Sorafenib Tosylate) Nilotinib Nivolumab Nolvadex (Tamoxifen Citrate) Nplate (Romiplostim) ...
  10. Drugs Approved for Kidney (Renal Cell) Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Avastin (Bevacizumab) Axitinib Bevacizumab Everolimus Inlyta (Axitinib) Nexavar (Sorafenib Tosylate) Pazopanib Hydrochloride Proleukin (Aldesleukin) Sorafenib Tosylate Sunitinib ...
previous · 1 · 2 · 3 · 4 · next
Refine by Type